More

    Finance

    Hindalco: Capex to remain in Rs 6,000-7,000 crore range in coming years: Satish Pai, Hindalco

    "I think that in Q1, we should probably do better than that because our cost of production is going to be a couple...

    EQT Private Capital Asia’s Mid-Market Growth Fund closes at more than double its target size, raising USD 1.6 billion in total fund commitments

    The Asia-focused mid-market buyout fund, which had an initial target size of USD 750 million, closes with USD 1.6 billion in total fund...

    Australia stocks higher at close of trade; S&P/ASX 200 up 0.79% By Investing.com

    Investing.com – Australia stocks were higher after the close on Monday, as gains in the , and sectors led shares higher. At...

    Japan stocks higher at close of trade; Nikkei 225 up 0.74% By Investing.com

    Investing.com – Japan stocks were higher after the close on Monday, as gains in the , and sectors led shares higher. At...

    South Africa’s Steenhuisen wages mission to stop ‘doomsday coalition’ By Reuters

    By Joe Bavier JOHANNESBURG (Reuters) - On paper, South Africa's election this week should present a golden opportunity for the opposition Democratic...

    markets: India in one of the best wealth creation and earning growth cycle for next 8-10 years: Vikas Khemani

    "There might be some psychological or emotional reaction in a shorter term, saying government would not be able to carry out this reform,...

    Armenian police detain more than 130 protesters in Yerevan, TASS cites ministry By Reuters

    TBILISI (Reuters) - Armenian police detained 137 protesters who were blocking streets in Yerevan as part of a series of anti-government protests,...

    Datopotamab Deruxtecan Showed Clinically Meaningful Overall Survival Improvement Versus Chemotherapy in Patients with Advanced Nonsquamous Non-Small Cell Lung Cancer in TROPION-Lung01 Phase 3 Trial

    In the overall trial population, survival results numerically favored Daiichi Sankyo and AstraZeneca (NASDAQ:)'s datopotamab deruxtecan but did not reach statistical significanceTROPION-Lung01 previously...

    divi’s laboratories shares: Divi’s Laboratories shares rally 5% post Q4 results. Should you buy, sell or hold?

    Shares of Divi’s Laboratories zoomed 5% on BSE in Monday's trade to hit its fresh 52-week high of Rs 4,335 as brokerages like...
    1...3,7073,7083,709...3,754Page 3,708 of 3,754

    Latest articles

    spot_imgspot_img

    Popular articles

    Featured

    Newsletter

    Subscribe to get the latest news, offers and special announcements.

    By subscribing, you're accepting to receive promotions.

    © Copyright - Newspaper WordPress Theme by TagDiv